The scale of the analysis is one of its distinguishing strengths. The investigators tested 19,523 respiratory specimens from children admitted to the hospital with acute respiratory infections, screening each sample for human adenovirus using targeted next-generation sequencing, a technique that allows simultaneous detection and initial genetic typing of the virus. Overall, 1,704 samples tested positive, corresponding to a detection rate of 8.7 percent. That figure underscores how substantial a burden adenovirus places on pediatric inpatient services in the region, particularly given that the study period spanned three full respiratory seasons following the disruption of the COVID-19 pandemic years.

Demographic patterns in the data were striking and statistically robust. Detection rates were significantly higher in boys than in girls, a difference the authors report with a P value of 0.002, and age proved to be an even stronger determinant of infection risk. Children between three and six years old showed the highest detection rate of any age group, at 11.9 percent, with significant heterogeneity across age strata overall. This preschool peak is consistent with the epidemiology of adenovirus in many settings, reflecting the combination of close contact in kindergartens and playgrounds, immature immune memory, and the high viral shedding that young children can sustain during respiratory illness.

Beyond simply measuring how often the virus appeared, the team went on to determine which genotypes were responsible. From the positive samples, 1,447 could be successfully genotyped, and the analysis revealed 14 distinct genotypes belonging to five of the seven human adenovirus species, designated A, B, C, E, and F. Two types towered over the rest: HAdV-3 accounted for 51.5 percent of genotyped infections and HAdV-7 for 18.4 percent, followed by HAdV-1 at 12.2 percent, HAdV-2 at 6.6 percent, HAdV-21 at 6.3 percent, HAdV-5 at 2.4 percent, and HAdV-4 at 1.3 percent, with remaining genotypes making up the final 1.3 percent. To confirm the sequencing-based typing, the researchers randomly selected positive samples for conventional PCR amplification of the hexon gene, the principal surface protein-coding region used in adenovirus classification, and performed phylogenetic analysis against reference sequences from GenBank.

Perhaps the most consequential finding is that genotype composition changed systematically with the age of the host. Preschool and school-aged children were infected mainly with HAdV-3 and HAdV-7, both members of species B, whereas infants and toddlers were predominantly infected with HAdV-3 and HAdV-1, the latter belonging to species C. The association between age group and genotype was highly significant, with a P value below 0.001. This age-stratified structure has practical implications: it suggests that the viruses circulating in daycare and school environments differ from those afflicting children in their first years of life, and that any vaccination or prevention strategy may need to account for these distinct transmission niches.

Seasonality added another layer of structure to the epidemiology. Adenovirus was detected year-round, but the detection rate varied markedly by season, peaking in winter at 13.4 percent of tested specimens. The seasonal pattern intersected with genotype in an unexpected way. Species B viruses, particularly HAdV-3 and HAdV-7, dominated the winter months, while species C viruses, especially HAdV-1, were more commonly identified in summer. This genotype-season coupling, significant at P below 0.001, implies that winter respiratory disease admissions driven by adenovirus are not simply more frequent but also caused by a different set of viral types than summer cases, a nuance that could inform the timing of clinical preparedness and laboratory typing efforts.

Temporal analysis across the three study years revealed an inter-annual shift in the viral population that may prove to be the study’s most cited observation. Before August 2023, species C adenoviruses were the predominant circulating group; after that point, species B took over as the dominant species. Such species-level turnover in a community setting is rarely documented with this level of resolution, and it raises questions about what ecological forces, whether waning population immunity, changes in contact patterns, or intrinsic viral fitness differences, drove the replacement. The authors’ data cannot answer that question definitively, but the documented shift provides a benchmark against which future surveillance in Tianjin and comparable regions can be measured.

The clinical correlations are equally important for pediatric practice. The main diagnoses among adenovirus-positive children included pneumonia, bronchitis, tonsillopharyngitis, and upper respiratory tract infections. Genotype-phenotype association analysis showed that HAdV-3 and HAdV-7 were the predominant types in pneumonia cases, whereas HAdV-3 and HAdV-1 were more commonly associated with tonsillopharyngitis and upper respiratory tract infections. Most critically, children infected with HAdV-7 were significantly more likely to develop severe pneumonia, an association with a P value below 0.001. This finding aligns with the established reputation of HAdV-7 as the most virulent of the common respiratory adenovirus types and highlights why molecular typing of adenovirus in hospitalized children is not merely an academic exercise but can carry direct prognostic value at the bedside.

For the study’s authors, the combined epidemiological, seasonal, and clinical picture supports a case for region-specific surveillance and targeted interventions. Because HAdV-3, HAdV-7, and HAdV-1 together accounted for the overwhelming majority of typed infections, they represent the logical priority targets for any multivalent vaccine formulated for this population. No licensed adenovirus vaccine is currently available for routine pediatric use in most countries, and existing military vaccines cover only types 4 and 7. The genotype distribution documented in Tianjin, with its clear dominance of type 3 and its age-specific and seasonal structure, offers exactly the kind of empirical evidence that vaccine developers and public health planners need when weighing which valences to include and how to prioritize rollout.

The study also demonstrates the value of combining modern sequencing platforms with classical molecular methods. Targeted next-generation sequencing enabled high-throughput screening and typing across nearly twenty thousand specimens, while hexon gene PCR and phylogenetic analysis provided confirmatory genotyping anchored to international reference databases. The retrospective design, approved by the Ethics Committee of Tianjin Children’s Hospital with a waiver of written informed consent because de-identified residual specimens were used, allowed the team to assemble a dataset of unusual breadth without additional burden on patients. As respiratory virus surveillance becomes increasingly genomic in the post-pandemic era, this work illustrates how sustained, genotype-resolved monitoring of a single pathogen in a single pediatric population can reveal patterns, from species turnover to genotype-specific severity, that would be invisible to conventional diagnostic testing alone, and it establishes a detailed baseline for tracking how adenovirus evolution continues to shape childhood pneumonia in northern China.

Subject of Research: Molecular epidemiology and clinical characteristics of human adenovirus in hospitalized children with respiratory infections in Tianjin, China

Article Title: A comprehensive analysis of molecular epidemiology and clinical characteristics of human adenovirus among hospitalized children with pneumonia in Tianjin, China, 2022–2025

Article References: Fang, Y., Dong, L., Hou, M., Lei, M., Guan, X., & Cai, C. (2026). A comprehensive analysis of molecular epidemiology and clinical characteristics of human adenovirus among hospitalized children with pneumonia in Tianjin, China, 2022–2025. BMC Infectious Diseases. https://doi.org/10.1186/s12879-026-14452-7

Image Credits: AI Generated

DOI: 10.1186/s12879-026-14452-7

Keywords: human adenovirus, pediatric pneumonia, acute respiratory infection, HAdV-3, HAdV-7, genotype surveillance, next-generation sequencing, hexon gene, seasonality, vaccine development, Tianjin, BMC Infectious Diseases

The study, published in BMC Infectious Diseases, was led by Yalin Sun and colleagues in the hospital’s Department of Pediatric Infectious Diseases. The team examined children aged eighteen years or younger who were hospitalized with acute respiratory tract infections between 5 January 2023 and 17 June 2025. Each child underwent a thirteen-target pharyngeal-swab assay covering the common respiratory pathogens, from respiratory syncytial virus and influenza to human adenovirus and Mycoplasma pneumoniae. The researchers collapsed these detections into eleven analytical groups and then asked a deceptively simple question: did the identity of the detected pathogen predict the child’s inflammatory biomarker levels or the length of their hospital stay?

The scale of the dataset lends the findings considerable weight. Of 6,093 hospitalized children included in the analysis, 2,076 tested negative on the respiratory panel, 3,343 had a single pathogen detected, and 674 carried detections of multiple targets simultaneously. Rather than treating every pathogen individually, the investigators defined three primary outcomes that map onto everyday clinical decisions: a high-sensitivity C-reactive protein value of at least 20 milligrams per liter, a procalcitonin value of at least 0.5 nanograms per milliliter, and a hospital stay lasting seven days or longer. These thresholds are commonly used at the bedside as rough markers of a bacterial process or a complicated course.

The statistical approach was deliberately conservative. Complete-case logistic regression models adjusted for age group, sex, testing year, and season, and the authors applied false discovery rate corrections to guard against spurious associations arising from the many comparisons inherent in a multi-pathogen panel. Sensitivity analyses probed the robustness of the results from several angles: biomarkers were also modeled as continuous variables, multiple-target detections were examined separately, recorded SARS-CoV-2 positivity was accounted for, and the analysis was restricted to children sampled within 24 or 48 hours of admission using both source records and chart-reviewed timing intervals.

Two pathogens stood out with sharply contrasting signatures. Human adenovirus detection was associated with roughly double the odds of an elevated inflammatory response compared with children whose panels came back negative. The adjusted odds ratio was 2.19 for a high-sensitivity C-reactive protein value of at least 20 milligrams per liter, with a 95 percent confidence interval of 1.63 to 2.96, and 1.93 for a procalcitonin value of at least 0.5 nanograms per milliliter, with a confidence interval of 1.34 to 2.77. In practical terms, a child whose swab revealed adenovirus was markedly more likely to show the kind of inflammatory surge that clinicians often associate with bacterial infection, even though adenovirus is a virus.

Mycoplasma pneumoniae told the opposite story in one respect and a striking one in another. Detection of this atypical bacterium was linked to lower odds of a procalcitonin value reaching 0.5 nanograms per milliliter, with an adjusted odds ratio of just 0.22 and a confidence interval of 0.13 to 0.37. Yet the same pathogen was the strongest predictor of a prolonged hospitalization in the entire study: children with Mycoplasma pneumoniae detections had 2.57 times the odds of staying seven days or longer, with a confidence interval of 1.99 to 3.31. The association with long stays persisted when the analysis was restricted to children sampled early, yielding adjusted odds ratios of 2.50 in the 24-hour subset and 2.76 in the 48-hour subset, suggesting that the finding was not an artifact of delayed testing after several days of illness.

Multiple detections carried their own signal. Children in whom two or more targets were identified had 2.21 times the odds of a hospital stay of at least seven days compared with panel-negative children, with a confidence interval of 1.73 to 2.82. Co-detection is increasingly recognized as common rather than exceptional in pediatric respiratory medicine, and this result adds to the evidence that a positive panel with more than one organism is not simply noise. Whether co-detected pathogens interact biologically, or whether multiple detections mark a different underlying illness severity, remains an open question that this observational design cannot resolve.

The authors are careful, and rightly so, about what these numbers do and do not mean. A retrospective cohort of routine clinical data cannot establish that a pathogen causes a longer stay or a higher biomarker value. Unmeasured bacterial infection, variation in treatment, differences in illness severity at presentation, and the clinical selection of which children get tested all could shape the observed associations. The study also relied on routinely recorded biomarkers rather than protocol-mandated sampling, and chest radiograph findings were classified from reports in a way the authors flag as unvalidated. These limitations are acknowledged explicitly in the paper, and the sensitivity analyses, while reassuring, do not convert association into causation.

Even with those caveats, the clinical implications are worth pondering. The adenovirus finding serves as a caution against over-relying on C-reactive protein and procalcitonin as bacterial discriminators: a vigorous inflammatory response in a child with a positive adenovirus swab may reflect the virus itself rather than a bacterial co-infection demanding antibiotics. Conversely, the Mycoplasma pneumoniae result suggests that a low procalcitonin does not guarantee a short or uncomplicated course. Mycoplasma infections in children are notorious for protracted coughing illness and, in some regions, rising macrolide resistance, and a biomarker pattern that looks reassuringly quiet may coexist with a hospitalization that stretches well past a week.

For researchers, the study illustrates the value of linking routine diagnostic panels to outcomes data at scale, and of stress-testing associations with early-sampling restrictions and timing reconciliation before publication. The supplementary materials document an unusually thorough audit trail, including chart-reviewed corrections of PCR timing records and analyses omitting individually corrected entries. For clinicians, the takeaway is more modest but useful: pathogen identity, inflammatory biomarkers, and hospital course each carry independent information, and none substitutes for the others. As multiplex panels become faster and cheaper, studies like this one help map which detections actually matter for the questions that keep a child in the hospital, and which are simply molecular footnotes to an illness that will resolve on its own schedule.

Subject of Research: Associations between multiplex respiratory pathogen detections, inflammatory biomarkers, and length of stay in children hospitalized with acute respiratory tract infections

Article Title: Respiratory panel detections, inflammatory biomarkers, and length of stay in children hospitalized with acute respiratory tract infections: a retrospective cohort study

Article References: Sun, Y., Li, S., Wang, Y., Zhang, S., Teng, S., & Qi, Z. (2026). Respiratory panel detections, inflammatory biomarkers, and length of stay in children hospitalized with acute respiratory tract infections: a retrospective cohort study. BMC Infectious Diseases. https://doi.org/10.1186/s12879-026-14559-x

Image Credits: AI Generated

DOI: 10.1186/s12879-026-14559-x

Keywords: acute respiratory tract infection, children, multiplex PCR, human adenovirus, Mycoplasma pneumoniae, procalcitonin, C-reactive protein, length of stay, biomarkers, pediatrics, retrospective cohort, hospitalization

The study, published in BMC Infectious Diseases, drew on throat swab samples collected from 34,404 pediatric patients aged 18 years or younger who presented with respiratory symptoms at the Affiliated Women and Children’s Hospital of Ningbo University. Rather than relying on a single targeted test, the laboratory team used multiplex polymerase chain reaction, a technique that amplifies and identifies the genetic material of several pathogens simultaneously, to screen every sample for 13 common viral and atypical bacterial respiratory pathogens. Demographic details, pathogen identities and the dates on which samples were collected were then retrieved from the hospital’s laboratory database and analyzed together to reveal who was infected, with what, and when.

The headline number from the surveillance effort is an overall pathogen positivity rate of 69.14 percent, meaning that roughly seven in ten children tested carried detectable genetic evidence of at least one of the pathogens on the panel. That figure underscores how densely pathogenic material circulates among symptomatic children and illustrates the value of broad molecular panels: many of these infections would be difficult to distinguish clinically, since fever, cough and wheezing can be produced by any of a dozen different agents. Multiplex detection allows epidemiologists to see the true composition of that microbial mix rather than inferring it from symptoms alone.

Within that mix, three pathogens stood out. Mycoplasma pneumoniae, an atypical bacterium that lacks a cell wall and attaches itself to the lining of the respiratory tract, was detected in 26.94 percent of the tested children, making it the leading cause of positive findings. Human rhinovirus, the virus best known as the chief culprit behind the common cold, came second at 16.29 percent. Human adenovirus, a DNA virus capable of causing everything from pharyngitis to pneumonia, ranked third at 9.00 percent. The prominence of Mycoplasma pneumoniae is particularly notable because, as an atypical bacterium, it does not respond to the beta-lactam antibiotics often prescribed empirically for respiratory complaints, so knowing that it dominates locally can shape more rational treatment decisions.

The analysis went beyond simple prevalence counts to ask whether pathogen positivity differed across patient groups. The researchers report significant differences in positivity rates between the sexes and across age groups, indicating that the burden of specific respiratory pathogens is not distributed evenly among children. Such demographic patterns matter for clinical practice: if certain age brackets carry a disproportionately high share of detections, pediatricians can calibrate their index of suspicion, and laboratories can anticipate demand for testing among particular populations. Age-structured susceptibility is also a key input for modeling how respiratory pathogens spread through households and schools, where mixing patterns differ sharply from those of adult populations.

Seasonality, a signature feature of respiratory disease that was famously disrupted during the height of the COVID-19 pandemic, re-emerges clearly in the Ningbo data. The study documents evident seasonal variation for certain pathogens, with detection rates rising and falling across the two calendar years of surveillance. Tracking these rhythms is more than an academic exercise. Hospitals can use seasonal profiles to anticipate surges in admissions, stock appropriate diagnostics and therapeutics, and time public health messaging. The post-COVID period offers a natural experiment in how respiratory pathogen ecology rebounds when masking, distancing and reduced mixing recede, and datasets like this one provide the ground truth against which such rebound theories can be tested.

Coinfection emerged as a substantial feature of the pediatric disease landscape. Among the samples that tested positive for at least one pathogen, 19.85 percent harbored more than one, with dual infections representing the most common configuration. Coinfections complicate both biology and bedside care. On the biological side, one pathogen can damage the airway epithelium in ways that facilitate the entry or proliferation of another, potentially deepening disease severity. On the clinical side, a positive result for a common, often mild virus such as rhinovirus does not rule out a concurrent bacterial infection requiring antibiotics. Multiplex panels make such mixed infections visible, which single-pathogen testing would leave hidden.

The authors, a team spanning the hospital’s clinical laboratory, pediatrics department and a municipal key laboratory, frame the findings as an epidemiological reference for managing pediatric respiratory infections in the post-COVID-19 era. Their conclusions highlight the significant roles of Mycoplasma pneumoniae, human rhinovirus and human adenovirus in children in Ningbo and underscore the need for continued surveillance. Sustained monitoring is precisely what allows health systems to detect shifts in pathogen dominance, spot unusual out-of-season activity and respond to outbreaks before they overwhelm pediatric wards. Given that respiratory pathogens can change their circulation patterns within a single season, longitudinal datasets of this scale are among the most valuable tools available to public health authorities.

Methodologically, the study’s strengths lie in its sample size and its systematic approach. More than 34,000 specimens tested over 24 consecutive months with a standardized 13-pathogen molecular panel provide a resolution that smaller, shorter studies cannot match. The retrospective design has inherent limits, of course: it captures children who presented to one hospital with respiratory symptoms, so the findings describe a clinical population rather than the community at large, and throat swabs may vary in sensitivity across pathogens and disease stages. The researchers note that the work used non-identifiable data extracted under an ethics approval and informed consent waiver from the hospital’s institutional review board, in line with the Declaration of Helsinki.

For the wider scientific and clinical community, the Ningbo study adds a detailed post-pandemic datapoint to a growing international effort to understand how respiratory pathogen epidemiology reorganized after COVID-19. Questions remain open about whether Mycoplasma pneumoniae’s leading position reflects a genuine rebound of that bacterium after years of suppressed transmission, a shift in immunity profiles among children who grew up during the pandemic, or local factors specific to eastern China. Continued multi-season, multi-site surveillance, ideally with consistent molecular panels, will be needed to separate these explanations. In the meantime, the study offers pediatricians a clear message: in the post-COVID era, the causes of childhood respiratory infection are numerous, frequently mixed, and follow seasonal scripts that are once again worth learning by heart.

Subject of Research: Prevalence of viral and atypical bacterial respiratory pathogens in pediatric acute respiratory infections in post-COVID-19 Ningbo, China

Article Title: Prevalence of viral and atypical bacterial respiratory pathogens among pediatric patients with acute respiratory infections after COVID-19 in Ningbo, China

Article References: Zhou, C., Lu, W., Chen, Y., Hu, Q., Zhu, L., & Liu, W. (2026). Prevalence of viral and atypical bacterial respiratory pathogens among pediatric patients with acute respiratory infections after COVID-19 in Ningbo, China. BMC Infectious Diseases. https://doi.org/10.1186/s12879-026-14531-9

Image Credits: AI Generated

DOI: 10.1186/s12879-026-14531-9

Keywords: Mycoplasma pneumoniae, human rhinovirus, human adenovirus, pediatric respiratory infections, multiplex PCR, coinfections, seasonal trends, COVID-19 pandemic, Ningbo China, epidemiology, BMC Infectious Diseases, surveillance